{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T02:48:04Z","timestamp":1773283684176,"version":"3.50.1"},"reference-count":69,"publisher":"Centers for Disease Control and Prevention (CDC)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Emerg. Infect. Dis."],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.3201\/eid2208.160229","type":"journal-article","created":{"date-parts":[[2016,6,26]],"date-time":"2016-06-26T02:14:00Z","timestamp":1466907240000},"source":"Crossref","is-referenced-by-count":16,"title":["Toward Developing a Preventive MERS-CoV Vaccine\u2014Report from a Workshop Organized by the Saudi Arabia Ministry of Health and the International Vaccine Institute, Riyadh, Saudi Arabia, November 14\u201315, 2015"],"prefix":"10.3201","volume":"22","author":[{"given":"Jean-Louis","family":"Excler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher J.","family":"Delvecchio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan E.","family":"Wiley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marni","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"In-Kyu","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kayvon","family":"Modjarrad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"Boujelal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vasee S.","family":"Moorthy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmad Salah","family":"Hersi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerome H.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"on behalf of the MERS-CoV Vaccine Working Group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1822","reference":[{"key":"key-10.3201\/eid2208.160229-201607151352-R1","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/S0140-6736(15)60454-8","article-title":"Middle East respiratory syndrome.","volume":"386","author":"Zumla","year":"2015","journal-title":"Lancet"},{"key":"key-10.3201\/eid2208.160229-201607151352-R2","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/S1473-3099(15)70090-3","article-title":"Presence of Middle East respiratory syndrome coronavirus antibodies in Saudi Arabia: a nationwide, cross-sectional, serological study.","volume":"15","author":"M\u00fcller","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"key-10.3201\/eid2208.160229-201607151352-R3","doi-asserted-by":"publisher","first-page":"e2015033","DOI":"10.4178\/epih\/e2015033","article-title":"2015 MERS outbreak in Korea: hospital-to-hospital transmission.","volume":"37","author":"Ki","year":"2015","journal-title":"Epidemiol Health"},{"key":"key-10.3201\/eid2208.160229-201607151352-R4","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/S2213-2600(15)00238-6","article-title":"Spread of MERS to South Korea and China.","volume":"3","author":"Hui","year":"2015","journal-title":"Lancet Respir Med"},{"key":"key-10.3201\/eid2208.160229-201607151352-R5","doi-asserted-by":"publisher","first-page":"7","DOI":"10.2807\/1560-7917.ES2015.20.25.21163","article-title":"Preliminary epidemiological assessment of MERS-CoV outbreak in South Korea, May to June 2015.","volume":"20","author":"Cowling","year":"2015","journal-title":"Euro Surveill"},{"key":"key-10.3201\/eid2208.160229-201607151352-R6","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/S1473-3099(13)70204-4","article-title":"Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study.","volume":"13","author":"Assiri","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"key-10.3201\/eid2208.160229-201607151352-R7","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1586\/17476348.2015.1027689","article-title":"An update on Middle East respiratory syndrome: 2 years later.","volume":"9","author":"Al-Tawfiq","year":"2015","journal-title":"Expert Rev Respir Med"},{"key":"key-10.3201\/eid2208.160229-201607151352-R8","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1517\/14712598.2015.1092518","article-title":"Middle East respiratory syndrome: current status and future prospects for vaccine development.","volume":"15","author":"Du","year":"2015","journal-title":"Expert Opin Biol Ther"},{"key":"key-10.3201\/eid2208.160229-201607151352-R9","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1038\/nm1015-1106","article-title":"MERS vaccines advance, but will humans or camels get the jab?","volume":"21","author":"Khamsi","year":"2015","journal-title":"Nat Med"},{"key":"key-10.3201\/eid2208.160229-201607151352-R10","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1586\/14760584.2015.1036033","article-title":"Middle East respiratory syndrome: obstacles and prospects for vaccine development.","volume":"14","author":"Papaneri","year":"2015","journal-title":"Expert Rev Vaccines"},{"key":"key-10.3201\/eid2208.160229-201607151352-R11","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.antiviral.2015.07.005","article-title":"Animal models of Middle East respiratory syndrome coronavirus infection.","volume":"122","author":"van Doremalen","year":"2015","journal-title":"Antiviral Res"},{"key":"key-10.3201\/eid2208.160229-201607151352-R12","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1128\/JVI.02935-13","article-title":"Adenosine deaminase acts as a natural antagonist for dipeptidyl peptidase 4-mediated entry of the Middle East respiratory syndrome coronavirus.","volume":"88","author":"Raj","year":"2014","journal-title":"J Virol"},{"key":"key-10.3201\/eid2208.160229-201607151352-R13","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1099\/vir.0.060640-0","article-title":"Wild-type and innate immune-deficient mice are not susceptible to the Middle East respiratory syndrome coronavirus.","volume":"95","author":"Coleman","year":"2014","journal-title":"J Gen Virol"},{"key":"key-10.3201\/eid2208.160229-201607151352-R14","doi-asserted-by":"publisher","first-page":"e69127","DOI":"10.1371\/journal.pone.0069127","article-title":"The Middle East respiratory syndrome coronavirus (MERS-CoV) does not replicate in Syrian hamsters.","volume":"8","author":"de Wit","year":"2013","journal-title":"PLoS One"},{"key":"key-10.3201\/eid2208.160229-201607151352-R15","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.it.2008.02.010","article-title":"Revisiting an old acquaintance: CD26 and its molecular mechanisms in T cell function.","volume":"29","author":"Ohnuma","year":"2008","journal-title":"Trends Immunol"},{"key":"key-10.3201\/eid2208.160229-201607151352-R16","doi-asserted-by":"publisher","first-page":"5195","DOI":"10.1128\/JVI.03764-13","article-title":"Mouse dipeptidyl peptidase 4 is not a functional receptor for Middle East respiratory syndrome coronavirus infection.","volume":"88","author":"Cockrell","year":"2014","journal-title":"J Virol"},{"key":"key-10.3201\/eid2208.160229-201607151352-R17","doi-asserted-by":"publisher","first-page":"9220","DOI":"10.1128\/JVI.00676-14","article-title":"Host species restriction of Middle East respiratory syndrome coronavirus through its receptor, dipeptidyl peptidase 4.","volume":"88","author":"van Doremalen","year":"2014","journal-title":"J Virol"},{"key":"key-10.3201\/eid2208.160229-201607151352-R18","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/nature12005","article-title":"Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC.","volume":"495","author":"Raj","year":"2013","journal-title":"Nature"},{"key":"key-10.3201\/eid2208.160229-201607151352-R19","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/nature12328","article-title":"Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26.","volume":"500","author":"Lu","year":"2013","journal-title":"Nature"},{"key":"key-10.3201\/eid2208.160229-201607151352-R20","doi-asserted-by":"publisher","first-page":"3659","DOI":"10.1128\/JVI.03427-14","article-title":"Generation of a transgenic mouse model of Middle East respiratory syndrome coronavirus infection and disease.","volume":"89","author":"Agrawal","year":"2015","journal-title":"J Virol"},{"key":"key-10.3201\/eid2208.160229-201607151352-R21","doi-asserted-by":"publisher","first-page":"4970","DOI":"10.1073\/pnas.1323279111","article-title":"Rapid generation of a mouse model for Middle East respiratory syndrome.","volume":"111","author":"Zhao","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key-10.3201\/eid2208.160229-201607151352-R22","doi-asserted-by":"publisher","first-page":"8738","DOI":"10.1073\/pnas.1510830112","article-title":"Pre- and postexposure efficacy of fully human antibodies against Spike protein in a novel humanized mouse model of MERS-CoV infection.","volume":"112","author":"Pascal","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key-10.3201\/eid2208.160229-201607151352-R23","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1056\/NEJMc1215691","article-title":"Pneumonia from human coronavirus in a macaque model.","volume":"368","author":"Munster","year":"2013","journal-title":"N Engl J Med"},{"key":"key-10.3201\/eid2208.160229-201607151352-R24","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.virol.2015.07.013","article-title":"Intratracheal exposure of common marmosets to MERS-CoV Jordan-n3\/2012 or MERS-CoV EMC\/2012 isolates does not result in lethal disease.","volume":"485","author":"Johnson","year":"2015","journal-title":"Virology"},{"key":"key-10.3201\/eid2208.160229-201607151352-R25","doi-asserted-by":"publisher","first-page":"e1004250","DOI":"10.1371\/journal.ppat.1004250","article-title":"Infection with MERS-CoV causes lethal pneumonia in the common marmoset.","volume":"10","author":"Falzarano","year":"2014","journal-title":"PLoS Pathog"},{"key":"key-10.3201\/eid2208.160229-201607151352-R26","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.3201\/eid2012.141280","article-title":"Replication and shedding of MERS-CoV in upper respiratory tract of inoculated dromedary camels.","volume":"20","author":"Adney","year":"2014","journal-title":"Emerg Infect Dis"},{"key":"key-10.3201\/eid2208.160229-201607151352-R27","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/nrmicro2090","article-title":"The spike protein of SARS-CoV\u2014a target for vaccine and therapeutic development.","volume":"7","author":"Du","year":"2009","journal-title":"Nat Rev Microbiol"},{"key":"key-10.3201\/eid2208.160229-201607151352-R28","doi-asserted-by":"publisher","first-page":"9804","DOI":"10.1073\/pnas.0403492101","article-title":"Contributions of the structural proteins of severe acute respiratory syndrome coronavirus to protective immunity.","volume":"101","author":"Buchholz","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key-10.3201\/eid2208.160229-201607151352-R29","doi-asserted-by":"publisher","first-page":"9939","DOI":"10.1128\/JVI.01048-13","article-title":"Identification of a receptor-binding domain in the S protein of the novel human coronavirus Middle East respiratory syndrome coronavirus as an essential target for vaccine development.","volume":"87","author":"Du","year":"2013","journal-title":"J Virol"},{"key":"key-10.3201\/eid2208.160229-201607151352-R30","doi-asserted-by":"publisher","first-page":"3169","DOI":"10.1016\/j.vaccine.2014.04.016","article-title":"Purified coronavirus spike protein nanoparticles induce coronavirus neutralizing antibodies in mice.","volume":"32","author":"Coleman","year":"2014","journal-title":"Vaccine"},{"key":"key-10.3201\/eid2208.160229-201607151352-R31","doi-asserted-by":"publisher","first-page":"2564","DOI":"10.1056\/NEJMc1313186","article-title":"A recombinant viruslike particle influenza A (H7N9) vaccine.","volume":"369","author":"Fries","year":"2013","journal-title":"N Engl J Med"},{"key":"key-10.3201\/eid2208.160229-201607151352-R32","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1093\/infdis\/jiv406","article-title":"A randomized, blinded, controlled, dose-ranging study of a respiratory syncytial virus recombinant fusion (f) nanoparticle vaccine in healthy women of childbearing age.","volume":"213","author":"Glenn","year":"2016","journal-title":"J Infect Dis"},{"key":"key-10.3201\/eid2208.160229-201607151352-R33","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.vaccine.2012.11.009","article-title":"Safety and immunogenicity of a Sf9 insect cell-derived respiratory syncytial virus fusion protein nanoparticle vaccine.","volume":"31","author":"Glenn","year":"2013","journal-title":"Vaccine"},{"key":"key-10.3201\/eid2208.160229-201607151352-R34","doi-asserted-by":"publisher","first-page":"e112602","DOI":"10.1371\/journal.pone.0112602","article-title":"Tailoring subunit vaccine immunity with adjuvant combinations and delivery routes using the Middle East respiratory coronavirus (MERS-CoV) receptor-binding domain as an antigen.","volume":"9","author":"Lan","year":"2014","journal-title":"PLoS One"},{"key":"key-10.3201\/eid2208.160229-201607151352-R35","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1016\/j.ebiom.2015.08.031","article-title":"Recombinant receptor binding domain protein induces partial protective immunity in rhesus macaques against Middle East respiratory syndrome coronavirus challenge.","volume":"2","author":"Lan","year":"2015","journal-title":"EBioMedicine"},{"key":"key-10.3201\/eid2208.160229-201607151352-R36","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1080\/21645515.2015.1021527","article-title":"Optimization of antigen dose for a receptor-binding domain-based subunit vaccine against MERS coronavirus.","volume":"11","author":"Tang","year":"2015","journal-title":"Hum Vaccin Immunother"},{"key":"key-10.3201\/eid2208.160229-201607151352-R37","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1093\/infdis\/jiv325","article-title":"Protective effect of intranasal regimens containing peptidic Middle East respiratory syndrome coronavirus fusion inhibitor against MERS-CoV infection.","volume":"212","author":"Channappanavar","year":"2015","journal-title":"J Infect Dis"},{"key":"key-10.3201\/eid2208.160229-201607151352-R38","doi-asserted-by":"publisher","first-page":"7045","DOI":"10.1128\/JVI.00433-14","article-title":"A conformation-dependent neutralizing monoclonal antibody specifically targeting receptor-binding domain in Middle East respiratory syndrome coronavirus spike protein.","volume":"88","author":"Du","year":"2014","journal-title":"J Virol"},{"key":"key-10.3201\/eid2208.160229-201607151352-R39","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1128\/JVI.02009-15","article-title":"Characterization and demonstration of value of a lethal mouse model of Middle East respiratory syndrome coronavirus infection and disease.","volume":"90","author":"Tao","year":"2016","journal-title":"J Virol"},{"key":"key-10.3201\/eid2208.160229-201607151352-R40","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/cmi.2015.03","article-title":"Identification of an ideal adjuvant for receptor-binding domain-based subunit vaccines against Middle East respiratory syndrome coronavirus.","volume":"13","author":"Zhang","year":"2016","journal-title":"Cell Mol Immunol"},{"key":"key-10.3201\/eid2208.160229-201607151352-R41","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1111\/imm.12462","article-title":"Systemic and mucosal immunity in mice elicited by a single immunization with human adenovirus type 5 or 41 vector-based vaccines carrying the spike protein of Middle East respiratory syndrome coronavirus.","volume":"145","author":"Guo","year":"2015","journal-title":"Immunology"},{"key":"key-10.3201\/eid2208.160229-201607151352-R42","doi-asserted-by":"publisher","first-page":"5975","DOI":"10.1016\/j.vaccine.2014.08.058","article-title":"Immunogenicity of an adenoviral-based Middle East respiratory syndrome coronavirus vaccine in BALB\/c mice.","volume":"32","author":"Kim","year":"2014","journal-title":"Vaccine"},{"key":"key-10.3201\/eid2208.160229-201607151352-R43","doi-asserted-by":"publisher","first-page":"8651","DOI":"10.1128\/JVI.00614-15","article-title":"Protective efficacy of recombinant modified vaccinia virus Ankara delivering Middle East respiratory syndrome coronavirus spike glycoprotein.","volume":"89","author":"Volz","year":"2015","journal-title":"J Virol"},{"key":"key-10.3201\/eid2208.160229-201607151352-R44","doi-asserted-by":"publisher","first-page":"11950","DOI":"10.1128\/JVI.01672-13","article-title":"Middle East respiratory syndrome coronavirus spike protein delivered by modified vaccinia virus Ankara efficiently induces virus-neutralizing antibodies.","volume":"87","author":"Song","year":"2013","journal-title":"J Virol"},{"key":"key-10.3201\/eid2208.160229-201607151352-R45","doi-asserted-by":"publisher","first-page":"11654","DOI":"10.1128\/JVI.01815-15","article-title":"A highly immunogenic and protective MERS-coronavirus vaccine based on recombinant MV vaccine platform.","volume":"89","author":"Malczyk","year":"2015","journal-title":"J Virol"},{"key":"key-10.3201\/eid2208.160229-201607151352-R46","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1126\/science.aad1283","article-title":"An orthopoxvirus-based vaccine reduces virus excretion after MERS-CoV infection in dromedary camels.","volume":"351","author":"Haagmans","year":"2016","journal-title":"Science"},{"key":"key-10.3201\/eid2208.160229-201607151352-R47","doi-asserted-by":"publisher","first-page":"e00650","DOI":"10.1128\/mBio.00650-13","article-title":"Engineering a replication-competent, propagation-defective Middle East respiratory syndrome coronavirus as a vaccine candidate.","volume":"4","author":"Almaz\u00e1n","year":"2013","journal-title":"MBio"},{"key":"key-10.3201\/eid2208.160229-201607151352-R48","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1177\/135965350701200702","article-title":"Safety and immunogenicity from a phase I trial of inactivated severe acute respiratory syndrome coronavirus vaccine.","volume":"12","author":"Lin","year":"2007","journal-title":"Antivir Ther"},{"key":"key-10.3201\/eid2208.160229-201607151352-R49","doi-asserted-by":"publisher","first-page":"6338","DOI":"10.1016\/j.vaccine.2008.09.026","article-title":"A SARS DNA vaccine induces neutralizing antibody and cellular immune responses in healthy adults in a Phase I clinical trial.","volume":"26","author":"Martin","year":"2008","journal-title":"Vaccine"},{"key":"key-10.3201\/eid2208.160229-201607151352-R50","doi-asserted-by":"publisher","first-page":"301ra132","DOI":"10.1126\/scitranslmed.aac7462","article-title":"A synthetic consensus anti-spike protein DNA vaccine induces protective immunity against Middle East respiratory syndrome coronavirus in nonhuman primates.","volume":"7","author":"Muthumani","year":"2015","journal-title":"Sci Transl Med"},{"key":"key-10.3201\/eid2208.160229-201607151352-R51","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1016\/S0140-6736(15)00239-1","article-title":"Safety, efficacy, and immunogenicity of VGX-3100, a therapeutic synthetic DNA vaccine targeting human papillomavirus 16 and 18 E6 and E7 proteins for cervical intraepithelial neoplasia 2\/3: a randomised, double-blind, placebo-controlled phase 2b trial.","volume":"386","author":"Trimble","year":"2015","journal-title":"Lancet"},{"key":"key-10.3201\/eid2208.160229-201607151352-R52","doi-asserted-by":"publisher","first-page":"7712","DOI":"10.1038\/ncomms8712","article-title":"Evaluation of candidate vaccine approaches for MERS-CoV.","volume":"6","author":"Wang","year":"2015","journal-title":"Nat Commun"},{"key":"key-10.3201\/eid2208.160229-201607151352-R53","doi-asserted-by":"publisher","first-page":"591","DOI":"10.2217\/imt.15.33","article-title":"Human neutralizing antibodies against MERS coronavirus: implications for future immunotherapy.","volume":"7","author":"Tang","year":"2015","journal-title":"Immunotherapy"},{"key":"key-10.3201\/eid2208.160229-201607151352-R54","doi-asserted-by":"crossref","first-page":"234ra59","DOI":"10.1126\/scitranslmed.3008140","article-title":"Potent neutralization of MERS-CoV by human neutralizing monoclonal antibodies to the viral spike glycoprotein.","volume":"6","author":"Jiang","year":"2014","journal-title":"Sci Transl Med"},{"key":"key-10.3201\/eid2208.160229-201607151352-R55","doi-asserted-by":"publisher","first-page":"7796","DOI":"10.1128\/JVI.00912-14","article-title":"Exceptionally potent neutralization of Middle East respiratory syndrome coronavirus by human monoclonal antibodies.","volume":"88","author":"Ying","year":"2014","journal-title":"J Virol"},{"key":"key-10.3201\/eid2208.160229-201607151352-R56","doi-asserted-by":"publisher","first-page":"8223","DOI":"10.1038\/ncomms9223","article-title":"Junctional and allele-specific residues are critical for MERS-CoV neutralization by an exceptionally potent germline-like antibody.","volume":"6","author":"Ying","year":"2015","journal-title":"Nat Commun"},{"key":"key-10.3201\/eid2208.160229-201607151352-R57","doi-asserted-by":"publisher","first-page":"3067","DOI":"10.1038\/ncomms4067","article-title":"Structure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitor.","volume":"5","author":"Lu","year":"2014","journal-title":"Nat Commun"},{"key":"key-10.3201\/eid2208.160229-201607151352-R58","doi-asserted-by":"publisher","first-page":"13769","DOI":"10.1128\/JVI.02232-14","article-title":"Effects of human anti-spike protein receptor binding domain antibodies on severe acute respiratory syndrome coronavirus neutralization escape and fitness.","volume":"88","author":"Sui","year":"2014","journal-title":"J Virol"},{"key":"key-10.3201\/eid2208.160229-201607151352-R59","doi-asserted-by":"publisher","first-page":"9113","DOI":"10.1128\/JVI.00233-12","article-title":"Increased antibody affinity confers broad in vitro protection against escape mutants of severe acute respiratory syndrome coronavirus.","volume":"86","author":"Rani","year":"2012","journal-title":"J Virol"},{"key":"key-10.3201\/eid2208.160229-201607151352-R60","doi-asserted-by":"publisher","first-page":"E2018","DOI":"10.1073\/pnas.1402074111","article-title":"Identification of human neutralizing antibodies against MERS-CoV and their role in virus adaptive evolution.","volume":"111","author":"Tang","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key-10.3201\/eid2208.160229-201607151352-R61","doi-asserted-by":"publisher","first-page":"10582","DOI":"10.1128\/JVI.00671-11","article-title":"Anti-severe acute respiratory syndrome coronavirus spike antibodies trigger infection of human immune cells via a pH- and cysteine protease-independent Fc\u03b3R pathway.","volume":"85","author":"Jaume","year":"2011","journal-title":"J Virol"},{"key":"key-10.3201\/eid2208.160229-201607151352-R62","first-page":"31","article-title":"SARS CoV subunit vaccine: antibody-mediated neutralisation and enhancement.","volume":"18","author":"Jaume","year":"2012","journal-title":"Hong Kong Med J"},{"key":"key-10.3201\/eid2208.160229-201607151352-R63","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.bbrc.2014.07.090","article-title":"Antibody-dependent SARS coronavirus infection is mediated by antibodies against spike proteins.","volume":"451","author":"Wang","year":"2014","journal-title":"Biochem Biophys Res Commun"},{"key":"key-10.3201\/eid2208.160229-201607151352-R64","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.vaccine.2006.08.011","article-title":"Antibodies against trimeric S glycoprotein protect hamsters against SARS-CoV challenge despite their capacity to mediate FcgammaRII-dependent entry into B cells in vitro.","volume":"25","author":"Kam","year":"2007","journal-title":"Vaccine"},{"key":"key-10.3201\/eid2208.160229-201607151352-R65","doi-asserted-by":"publisher","first-page":"12201","DOI":"10.1128\/JVI.06048-11","article-title":"A double-inactivated severe acute respiratory syndrome coronavirus vaccine provides incomplete protection in mice and induces increased eosinophilic proinflammatory pulmonary response upon challenge.","volume":"85","author":"Bolles","year":"2011","journal-title":"J Virol"},{"key":"key-10.3201\/eid2208.160229-201607151352-R66","doi-asserted-by":"publisher","first-page":"e35421","DOI":"10.1371\/journal.pone.0035421","article-title":"Immunization with SARS coronavirus vaccines leads to pulmonary immunopathology on challenge with the SARS virus.","volume":"7","author":"Tseng","year":"2012","journal-title":"PLoS One"},{"key":"key-10.3201\/eid2208.160229-201607151352-R67","doi-asserted-by":"publisher","first-page":"8597","DOI":"10.1128\/JVI.00983-14","article-title":"Effects of toll-like receptor stimulation on eosinophilic infiltration in lungs of BALB\/c mice immunized with UV-inactivated severe acute respiratory syndrome-related coronavirus vaccine.","volume":"88","author":"Iwata-Yoshikawa","year":"2014","journal-title":"J Virol"},{"key":"key-10.3201\/eid2208.160229-201607151352-R68","doi-asserted-by":"publisher","first-page":"e0003782","DOI":"10.1371\/journal.pntd.0003782","article-title":"Impact of the neglected tropical diseases on human development in the Organisation of Islamic Cooperation Nations.","volume":"9","author":"Hotez","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"key-10.3201\/eid2208.160229-201607151352-R69","doi-asserted-by":"publisher","first-page":"e0003852","DOI":"10.1371\/journal.pntd.0003852","article-title":"Vaccine science diplomacy: expanding capacity to prevent emerging and neglected tropical diseases arising from Islamic State (IS)\u2013held territories.","volume":"9","author":"Hotez","year":"2015","journal-title":"PLoS Negl Trop Dis"}],"container-title":["Emerging Infectious Diseases"],"original-title":[],"link":[{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/22\/8\/16-0229_article","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T23:27:57Z","timestamp":1732922877000},"score":1,"resource":{"primary":{"URL":"http:\/\/wwwnc.cdc.gov\/eid\/article\/22\/8\/16-0229_article.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":69,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2016,8]]}},"URL":"https:\/\/doi.org\/10.3201\/eid2208.160229","relation":{},"ISSN":["1080-6040","1080-6059"],"issn-type":[{"value":"1080-6040","type":"print"},{"value":"1080-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8]]}}}